IP Library Granted Patent US 10,889,849
Granted Patent B2
US 10,889,849 · App. 15/725,780 · Granted Jan 12, 2021

Oxidized glutathione assay

Inventors: Fen Huang (Madison, WI); Dieter Klaubert (Arroyo Grande, CA); John Shultz (Verona, WI); Wenhui Zhou (San Luis Obispo, CA)
Assignee: PROMEGA CORPORATION
C12Q1/48G01N21/763G01N2333/91177
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,889,849
App. No.
15/725,780
Granted
Jan 12, 2021
Kind
B2
Abstract

The present invention provides an assay for detection of oxidized glutathione (GSSG).

Claims (20)

1. A method for determining GSH:GSSG ratio in a sample, the method comprising:

(a) providing a first portion of the sample and a second portion of the sample;

(b) contacting the first portion of the sample with a sulfhydryl modifying agent to provide a modified first sample portion;

(c) adding to the modified first sample portion an excess of a reducing agent, glutathione-S-transferase, and a substrate for a glutathione-S-transferase, which is converted to a signal-generating compound in the presence of GSH and glutathione-S-transferase, wherein the reducing agent inactivates the sulfhydryl alkylating agent and reduces any GSSG to GSH, to form a first solution;

(d) measuring the signal of the first solution, wherein neither the inactivated sulfhydryl alkylating agent nor the reducing agent is removed from the first solution;

(e) contacting the second portion of the sample with glutathione-S-transferase and a substrate for a glutathione-S-transferase, which is converted to a signal-generating compound in the presence of GSH and glutathione-S-transferase to form a second solution;

(f) measuring the signal of the second solution; and

(g) comparing the signal of the second solution to the signal of the first solution to determine the GSH:GSSG ratio.

2. The method of claim 1 wherein the sample comprises a cell, media, plasma, serum, blood, or tissue extract.

3. The method of claim 1 further comprising contacting the sample with a lysing agent prior to step a.

4. The method of claim 1 wherein the signal from the first solution and the signal from the second solution is fluorescence.

5. The method of claim 1 wherein the signal from the first solution and the signal from the second solution is luminescence.

6. The method of claim 1 wherein the substrate is a luciferin derivative, which is converted to luciferin in the presence of GSH and glutathione-S-transferase.

7. The method of claim 1 wherein the substrate is a compound of formula (III)

wherein X is N or O;

wherein R 1 , R 2 , R 3 , R 4 and R 5 are independently H, C 1-6 alkyl, CF 3 , halogen, NO 2 , CO 2 R, wherein R is H or C 1-6 alkyl, or any two adjacent R 1 -R 5 can form a fused ring provided that at least one of R 1 , R 3 or R 5 is NO 2 and not all three are NO 2 .

8. The method of claim 7 wherein the fused ring is benzo, naphtho, or heterocyclic.

9. The method of claim 1 wherein the substrate is a compound of formula

10. The method of claim 1 wherein the sulfhydryl modifying agent is N-ethylmaleimide (NEM).

11. The method of claim 1 wherein the reducing agent is dithiothreitol (DTT).

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2018
From: HUANG, FEN; KLAUBERT, DIETER; SHULTZ, JOHN; ZHOU, WENHUI
To: PROMEGA CORPORATION
Reel/Frame 044847/0001 →